Voloridge Investment Management, LLC Atea Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $2.93 Million - $4.5 Million	-549,912 Reduced 67.45%	265,365 $1.88 Million
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $1.92 Million - $3.21 Million	-349,190 Reduced 29.99%	815,277 $5.89 Million
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $6.96 Million - $40.4 Million	907,051 Added 352.37%	1,164,467 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$21.33 - $35.06 $448,655 - $737,452	-21,034 Reduced 7.55%	257,416 $9.03 Million
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $5.35 Million - $16.5 Million	278,450 New	278,450 $5.98 Million

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $281M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.